Patient Profiling and Outcome Assessment in Spinal Cord Stimulation for Chronic Back and/or Leg Pain
Unknown statusNCT05349695
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The PROSTIM study is an ongoing prospective, multicentric and observational clinical study. Patients are recruited in three different centers in Eastern Belgium from May 2018 onwards. This real-world data collection approaches the outcome assessment of daily medical practice. A hierarchical cluster analysis is used to identify significant patient clusters based on the Visual Analogue Scale (VAS), Oswestry disability index (ODI), Pain Vigilance and Awareness Questionnaire (PVAQ), Pain Catastrophizing Scale (PCS) and EuroQol with five dimensions for health-related quality of life (EQ-5D). Patient clusters will be assessed on the change in biopsychosocial variables after six weeks, three and twelve months. Secondary outcomes include the comparison of pain medication use, SCS parameters, treatment satisfaction and return to work.
Study details
- Official title
- Patient Profiling and Outcome Assessment in Spinal Cord Stimulation for Chronic Back and/or Leg Pain: Study Protocol for a Prospective, Multicentric Observational Study (the PROSTIM Study)
- Conditions
- Interventions
- Sponsor
- Studie- & Opleidingscentrum Neurochirurgie Virga Jesse
- Collaborators
- Medtronic
- Start date
- 2022-05-01
- Primary completion
- 2023-05
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Belgium
- Total sites listed
- 3
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Male/female over 18 years old. * Chronic intractable back and/or leg pain (PSPS T2), refractory to conservative treatment measures. * Positive recommendation after multidisciplinary assessment including psychiatric assessment. * Patients are capable of giving written informed consent. Exclusion Criteria: * Negative recommendation after multidisciplinary assessment (ex. psychiatric disorders). * Insufficient improvement during trial period. * Previous SCS implantation. * Removal due to complication (infection, loss of function,...) * Surgical contraindication (infection of surgical site, coagulation disorders,..) * Pregnancy.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05349695